6 wyniki
FIELD OF THE INVENTION
The present invention relates to the generation of mature dendritic cells and their use in cell therapy and to educate immune effector cells. The mature dendritic cells can be generated from immature dendritic cells.
BACKGROUND
Cell therapy utilizes modified antigen presenting
FIELD OF THE INVENTION
The present invention relates to the generation of mature dendritic cells and their use in cell therapy and to educate immune effector cells. The mature dendritic cells can be generated from immature dendritic cells.
BACKGROUND
Cell therapy utilizes modified antigen presenting
FIELD OF THE INVENTION
The present invention relates to the generation of mature dendritic cells and their use in cell therapy and to educate immune effector cells. The mature dendritic cells can be generated from immature dendritic cells.
BACKGROUND
Cell therapy utilizes modified antigen presenting
FIELD OF THE INVENTION
The present invention relates to the generation of mature dendritic cells and their use in cell therapy and to educate immune effector cells. The mature dendritic cells can be generated from immature dendritic cells.
BACKGROUND
Cell therapy utilizes modified antigen presenting
FIELD OF THE INVENTION
The present invention relates to the generation of mature dendritic cells and their use in cell therapy and to educate immune effector cells. The mature dendritic cells can be generated from immature dendritic cells.
BACKGROUND
Cell therapy utilizes modified antigen presenting
FIELD OF THE INVENTION
This invention relates to a novel and useful method for the treatment of cancerous tumors in animals and man and more particularly it relates to treatment of animal or human cancers through the administration of C-Reactive Proteins in combination with proteins having tumor